MedTrace Logo

Brief Behavioral Therapy for Insomnia (bBT-I) for Depressed Outpatients With Refractory Insomnia

NCT00610259 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2009-09-18

No results posted yet for this study

Summary

The purpose of this study is to examine the effectiveness of brief behavioral therapy for insomnia (bBT-I) in addition to treatment as usual (TAU) in comparison with TAU alone for refractory insomnia among patients with major depression in partial remission.

Conditions

Interventions

BEHAVIORAL

brief behavioral therapy for insomnia (bBT-I)

4 50-minute individual sessions every week for 4 weeks

OTHER

Treatment as usual (TAU)

The psychiatrist-in-charge sees the patient once every 2 weeks for approximately 10 minutes each to monitor pharmacotherapy.

Sponsors & Collaborators

  • Kochi University

    collaborator OTHER

  • Nagoya City University

    lead OTHER

Principal Investigators

  • Toshiaki A Furukawa, MD, PhD · Nagoya City University Graduate School of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2009-07-31
Completion
2009-08-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00610259 on ClinicalTrials.gov